S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13

Mediclinic International Share Forecast, Price & News

GBX 291.60
-6.60 (-2.21%)
(As of 12/3/2021 04:35 PM ET)
Today's Range
50-Day Range
52-Week Range
473,943 shs
Average Volume
548,356 shs
Market Capitalization
£2.15 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive MDC News and Ratings via Email

Sign-up to receive the latest news and ratings for Mediclinic International and its competitors with MarketBeat's FREE daily newsletter.

Mediclinic International logo

About Mediclinic International

Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 17 hospitals, 2 day case clinics, 3 outpatient clinics, and 110 theatres with approximately 1,893 inpatient beds in Switzerland; 52 hospitals, 10 day case clinics, 8 sub-acute hospitals, and 305 theatres in South Africa and Namibia with approximately 8,792 inpatient beds; and 7 hospitals, 2 day case clinics, 18 outpatient clinics, and 38 theatres with approximately 927 inpatient beds in the United Arab Emirates. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.


See More Headlines

Industry, Sector and Symbol

Medical Care
Year Founded

Sales & Book Value

Annual Sales
£3.16 billion
Cash Flow
GBX 52.03 per share
Book Value
GBX 412.30 per share


Pretax Margin




Free Float
Market Cap
£2.15 billion


Overall MarketRank

1.69 out of 5 stars

Analyst Opinion: 2.5Community Rank: 3.9Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Mediclinic International (LON:MDC) Frequently Asked Questions

Is Mediclinic International a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Mediclinic International in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Mediclinic International stock.
View analyst ratings for Mediclinic International
or view top-rated stocks.

How has Mediclinic International's stock been impacted by Coronavirus (COVID-19)?

Mediclinic International's stock was trading at GBX 335.70 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MDC shares have decreased by 13.1% and is now trading at GBX 291.60.
View which stocks have been most impacted by COVID-19

What price target have analysts set for MDC?

2 Wall Street analysts have issued 1 year price objectives for Mediclinic International's shares. Their forecasts range from GBX 340 to GBX 385. On average, they expect Mediclinic International's share price to reach GBX 362.50 in the next year. This suggests a possible upside of 24.3% from the stock's current price.
View analysts' price targets for Mediclinic International
or view top-rated stocks among Wall Street analysts.

Who are Mediclinic International's key executives?

Mediclinic International's management team includes the following people:
  • Dr. Carel Aron van der Merwe, Group CEO & Exec. Director (Age 58, Pay $601k)
  • Mr. Petrus Jurgens Myburgh, Group CFO & Exec. Director (Age 46, Pay $442k)
  • Dr. Dirk C. Le Roux, Group Chief Information Officer (Age 61)
  • Mr. James Arnold, Head of Investor Relations
  • Mr. Magnus U. Oetiker, Group Chief Strategy and HR Officer (Age 49)
  • Mr. Gert C. Hattingh, Group Chief Governance Officer (Age 56)
  • Mr. Biren Valodia, Chief Marketing Officer of Medi-Clinic Southern Africa
  • Ms. Clara Findlay, Chief Legal Officer of Medicalinic Southern Africa
  • Mr. Wimpie Aucamp, Chief Operating Officer of Medi-Clinic for Southern Africa
  • Greg Van Wyk, Chief HR Officer of Medicalinic Southern Africa

What other stocks do shareholders of Mediclinic International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mediclinic International investors own include Intu Properties (INTU), Capital & Counties Properties PLC (CAPC), Rdi Reit (RDI), British American Tobacco (BATS), Central Asia Metals (CAML), DRDGOLD (DRD), UK Oil & Gas (UKOG), Spire Healthcare Group (SPI), Premier Oil (PMO) and Ferrexpo (FXPO).

What is Mediclinic International's stock symbol?

Mediclinic International trades on the London Stock Exchange (LON) under the ticker symbol "MDC."

How do I buy shares of Mediclinic International?

Shares of MDC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Mediclinic International's stock price today?

One share of MDC stock can currently be purchased for approximately GBX 291.60.

How much money does Mediclinic International make?

Mediclinic International has a market capitalization of £2.15 billion and generates £3.16 billion in revenue each year.

How many employees does Mediclinic International have?

Mediclinic International employs 1,773 workers across the globe.

What is Mediclinic International's official website?

The official website for Mediclinic International is www.mediclinic.com.

Where are Mediclinic International's headquarters?

Mediclinic International is headquartered at 6th Floor 65 Gresham Street, LONDON, EC2V 7NQ, United Kingdom.

How can I contact Mediclinic International?

Mediclinic International's mailing address is 6th Floor 65 Gresham Street, LONDON, EC2V 7NQ, United Kingdom. The company can be reached via phone at +44-20-79549600.

This page was last updated on 12/5/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.